Download progress in cancer drug resistance research pdf. Because cancer cells within the same tumor often have a variety of molecular alterations, this socalled intrinsic resistance is common. Overcoming multidrug resistance in cancer stem cells. The reversal of antineoplastic drug resistance in cancer. Cancer stem cells cscs are a subpopulation of cancer cells with high clonogenic capacity and ability to reform parental tumors upon transplantation. Drug resistance of cancer cells is the main reason of poor prognosis of tumor patients. For example, poorer outcome of cisplatin treatment in gastric cancer patients was found to be associated with her2 overexpression18. Understanding the genetic mechanisms of cancer drug resistance using genomic approaches xueda hu1 and zemin zhang1,2, a major obstacle in precision cancer medicine is the inevitable resistance to targeted therapies. Resistance to therapy has been shown for several types of csc and, therefore, they have been. Many patients who experience breast cancer relapse struggle.
Various mechanisms of resistance, such as abc transportermediated drug efflux, have been discovered using established model cancer cell lines. Ethnicity influences breast cancer stem cells drug resistance. In other cases of resistance, cancer cells may adapt to the drug while it is being administered, acquiring molecular changes that allow them to escape its effects. The mutations likely rendered the tumor cells insensitive to interferon secreted by activated t cells, resulting in less tumor antigen presentation to the immune system and resistance to interferoninduced growth arrest. However, it suffers from drug efflux mediated by various drug transporter proteins and in many cases fails to produce curative clinical outcomes.
The goal of this study was to determine whether tgf. The journal focuses on pharmacological aspects of drug resistance and its reversal, including drug design, drug delivery, drug distribution and cellular drug resistance, etc. Sirt1 sirna enhances cellular response in the drugresistant cells by an additional 25% to 30%, resulting in a total cell death of 45% to 50%. One of the main causes of failure in the treatment of cancer is the development of drug resistance by the cancer cells. View enhanced pdf access article on wiley online library html view download pdf for offline viewing. Categories of mechanisms that can enable or promote direct or indirect drug resistance in human cancer cells. Secondary resistant mutations in cancer cells arise in response to certain small molecule inhibitors.
In the present study, a novel selenadiazole derivative has been evaluated and found to be able to antagonize the doxorubicin dox resistance of mcf7 cells under simulated diabetes conditions. Stromal cells confer drug resistance to breast cancer. Therefore, we investigated the relationships, among the telomerase activity, telomere length and the expression of multidrug resistance genes in colorectal cancer cell lines cultivated with anti cancer drugs. Drug resistance mechanisms of cancer stemlike cells and. Overcoming drug resistance in cancer chemotherapy by using nms as delivery systems is a very hot area of research in this century. Cellular morphology and cell cycle were determined and the suppressive subtracted hybridization ssh assay was performed to. However, most current research is focused on tumorspecific factors and. A matter of combination therapy article pdf available in cancers 1012.
Download cancer drug resistance cancer drug discovery. Drug resistance is a serious impediment to the treatment of cancer. Progress in understanding the molecular basis of drug resistance in cancer promises more effective treatments. Drug resistance to chemotherapeutics is a recurrent issue plaguing many cancer treatment regimens. While resistance to chemotherapy treatments is not necessary to define cscs, drug resistance is commonly associated with csc populations. One biochemical mechanism for resistance is when cancer cells emit a substance called pglycoprotein, which can remove the chemotherapy drug from the cancer cell. This section is intended to introduce some of the main ways in which cancer cells can resist treatments. Novel compounds line up to combat drug resistance in cancer cells. Many mechanisms of drug resistance have been found 2, 3. Furthermore, at least in some cases, refractoriness to treatment can be reversed by epigenetic reprogramming, and combination. In a mouse model of psychological stress the concentrations of both cortisol and noradrenaline were increased in the plasma. Drug combinations to overcome treatment resistance. Download and read free online drug resistance in cancer cells from springer. Nigel hawkes investigates cancer will be conquered only by outwitting its ability to evolve more rapidly than the drugs treating it, the institute of cancer research has decided.
Unfortunately these very same abc efflux pumps afford protection to cancer stem cells in tumors, shielding them from the adverse effects of chemotherapy. Dec 14, 2010 identification of molecular pathways essential for cancer stem cells is critical for understanding the underlying biology and designing effective cancer therapeutics. Resistance to anti cancer drugs can be acquired by several mechanisms within neoplastic cells, defined as 1 alteration of drug. As identifying cscs correctly is still difficult, the relationship between cscs and drug resistance is not. Drug resistance remains a great challenge in the treatment of pancreatic cancer.
Aguilar, in nanomaterials for medical applications, 20. A new mechanism of drug resistance in breast cancer cells. May 16, 2019 can a new research institute usher in a new era of cancer management. However, the mechanisms involved remain poorly understood. It has launched a new programme to tackle what its chief executive, paul workman, calls the biggest challenge in cancer biologycontrolling. Concurrent experiments with the smallmolecule chemotherapeutic, doxorubicin, show aggressive resistance onset in cancer cells, a lack of efficacy against drug resistant cancer cell lines, and a failure to prevent cancer cell migration. Lovo and dld1 cells were continuously grown in the presence of both. The development of resistance is a problem shared by both classical chemotherapy and targeted therapy. Cancer cells express multiple drug resistance mdr by initially developing resistance to a single anticancer drug, and slowly to various anticancer agents that are structurally similar but possess different mechanisms of action. Resistance to chemotherapeutic agents can involve various intrinsic cellular processes including drug efflux, increased resistance to apoptosis, increased dna damage repair capabilities in response to platinum salts or other dnadamaging drugs, drug inactivation, drug target. The resistance of cancer cells to various therapeutic agents and modalities is a crucial issue in clinical oncology. One way cancer cells accomplish this is by catching the intruding drug and throwing it out of the cell before it can act. Novel compounds line up to combat drug resistance in.
Review article overcoming multidrug resistance in cancer. Resistance to anti cancer drugs can be acquired by several mechanisms within neoplastic cells, defined as 1 alteration of. Cancer stem cells cscs in drug resistance and their. Drug transporters in stem cells stem cells have many properties that separate them from mature, differentiated cells. In the traditional view, cancer cells that survived during chemotherapy and acquired drug resistance gave rise to a population of drug resistant cancer cells. Cancer cells treated with drug x may undergo emt to acquire. Download pdf multidrug resistance, the principal mechanism by which many cancers. Hyperglycemia is an important factor for chemoresistance of breast cancer patients with diabetes. The inability of cancer drugs to destroy metastatic tumors is the major reason why cancer therapy fails. Tremendous effort and progress has been made over the past few years to understand the biochemical and genetic mechanisms under. Drug resistance and combating drug resistance in cancer. Thermo and ph dualcontrolled charge reversal amphiphilic. Colonies with a diameter greater than 75 lm for panc1 and greater 30 lm for hpaca1 cells were counted as spheres.
If cancer cells can survive after therapy, they give rise to relapse and metastasis, which are the almost all the causes of cancer related death37. Drug combinations to overcome treatment resistance national. Intrigued by the significant increases in stat3 phosphorylation and mitochondrial ocr in oncogeneaddicted therapyresistant cancer cells, we set out to investigate if the increase in stat3 phosphorylation associated with oncogeneaddicted tki resistance was also the effector mechanism triggering the metabolic switch to oxphos and. Various mechanisms that have been proposed include enhanced intracellular concentration of the drug by endocytosis, 1. Cancers have the ability to develop resistance to traditional therapies, and the increasing prevalence of these drug resistant cancers necessitates further research and treatment development. Adrenaline was shown to upregulate multi drug resistance 1 mdr1 in breast cancer cells, and reduce sensitivity to paclitaxel through a reduction of accumulation of the drug within the cell.
The reversal of antineoplastic drug resistance in cancer cells by. Metabolic reprogramming of oncogeneaddicted cancer cells to. In addition, breast cancer exosomes derived from metastatic breast cancer cells, mdamb231 and 4t1, revealed the higher enrichment in mirnas compared to breast cancer exosomes derived from nonmetastatic breast cancer cells, mcf7. Altered metabolic pathways help cancer cells to proliferate at a rate higher than normal, adapt to nutrient limited conditions, and develop drug resistance phenotypes. Apr 21, 2014 most drugs used to treat lung, breast and pancreatic cancers also promote drug resistance and ultimately spur tumor growth. Members of the atpbinding cassette abc transporter family proteins enable this efflux and are important, wellstudied regulators at the plasma membranes of healthy cells. The arsenal that the cancer cell uses to accomplish this. Because the warburg effect and hypoxia are frequently seen in human cancers, these findings may have broad clinical implications. Many drugs have been designed or discovered and used to kill cancer cells. Screening common signaling pathways associated with drug. The role of deubiquitinating enzymes in cancer drug resistance.
Studies on mechanisms of cancer drug resistance have yielded important information. Selenadiazole derivatives antagonize hyperglycemiainduced. The paradigm that drug resistance originates in the stemcell phenotype might stimulate new strategies for the development of anticancer therapies. Unfortunately, novel drug development by cell and molecular biologists, often neglects the pharmacology of a drug. For example, drugs can be prevented from entering the cells. The orphan drug tiopronin can kill cancer cells expressing high levels of mdr1. The macromolecular chemotherapeutic agents readily selfassemble into welldefined nanoparticles and show excellent activity in vitro against multiple cancer cell. The principle mechanism of protection of stem cells is through the expression of atpbinding cassette abc transporters. Dox is an anthracycline antibiotic that is the standard of care for many cancer patients. Understanding the genetic mechanisms of cancer drug. A recent cell paper highlights how changes at the chromatin level control drug sensitivity and provides insight into more effective strategies for treating cancer with combination therapies.
Cancer drug resistance is an open access journal, focusing on pharmacological aspects of drug resistance and its reversal, molecular mechanisms of drug resistance and drug classes, etc. Gene heterogeneities and mutations have been shown to play an important role in influencing drug efficacy and resistance in lung cancer. The use of natural products to target cancer stem cells. Researchers at the university of california, san diego school of medicine have discovered a biomarker called cd61 on the surface of drug resistant tumors that appears responsible for inducing tumor metastasis by enhancing the stem celllike properties of cancer cells.
Chemotherapy resistance can arise due to several host or tumorrelated factors. To circumvent resistance issues, we have designed a new class of macromolecules as selfcontained chemotherapeutic agents. The design of cancer chemotherapy has become increasingly sophisticated, yet there is no cancer treatment that is 100 percent effective against disseminated cancer. Thus, it is important to understand the characteristics and mechanisms by which cscs display resistance to therapeutic agents. One of the most studied mechanisms of cancer drug resistance involves reducing drug accumulation by enhancing efflux. Download the ebook cancer drug resistance cancer drug discovery and development in pdf or epub format and read it directly on your mobile phone, computer or any device. The journal focuses on pharmacological aspects of drug resistance and its reversal, including drug design, drug delivery, drug distribution and cellular drug resistance. Clinically, drug resistance may develop either prior to drug therapy, or due to drug therapy. How cancers evolve drug resistance the scientist magazine. In figure 1, a schematic overview of potential resistance mechanisms is given. Thermo and ph dualcontrolled charge reversal amphiphilic graft copolymer micelles for overcoming drug resistance in cancer cells haitao zhang, a xiaodong fan, a fei li, b rongtian suo, a hui li, a zhen yang, a wanbin zhang, a yang bai c and wei tian a. Sheng chen1 and huiqin guo2 abstract multidrug resistance mdr, defined as the resistance of cancer cells. Drug resistance is a wellknown phenomenon leading to a reduction in the effectiveness of pharmaceutical treatments. Chemical approaches to targeting drug resistance in cancer.
Stromal cells confer drug resistance to breast cancer cells in a kinetic coculture model ht1080 nuclight red abstract the tumor microenvironment is fundamentally involved in the response of a tumor to anti cancer therapies. Cancer is a leading cause of death worldwide accounting to % of all deaths. Abc transporters including abcg, abcb, and abcc, to name but a few. Pancreatic cancer bxpc3 cells were stably transfected with tgf. One of the impediments faced by patients with breast cancer is treatment or drug resistance. Mechanisms of drug resistance that increase drug efflux from cancer cells it came as something of a surprise that the major mechanism of multidrug resistance in cultured cancer cells was the expression of an energydependent drug ef. Cancers free fulltext secondary resistant mutations. Small molecule compound opb is a novel oxphos inhibitor. Intrinsic drug resistance may exist in cancer cells prior to therapies due to the presence of genetic mutations of genes involved in cancer cell growth andor apoptosis. Multidrug resistance is a major problem in successful cancer chemotherapy. Using clinical drug resistance to kill cancer cells.
F cancer stem cell sphere assay showing reduced sphereforming capacity of panc1 and hpaca1 in mir203 overexpression cells. Cancer chemotherapy resistance mdr is the innate andor acquired ability of cancer cells to evade the effects of chemotherapeutics and is one of the most pressing major dilemmas in cancer therapy. Additionally, the polymers showed anticancer efficacy in a hepatocel. Drug resistance and cancer stem cells estudo geral. Ethnicity influences breast cancer stem cells drug. While it is widely held that the phenomenon is genetic in nature, emerging evidence suggests that nongenetic mechanisms may also be important.
For example, some mutations decrease or abrogate the affinity of the drug for the protein. Drug resistance in cancer an overview sciencedirect topics. Drug resistance, epigenetics, and tumor cell heterogeneity. Cancer cell article repression of stressinduced line1 expression protects cancer cell subpopulations from lethal drug exposure gulfem dilek guler,1,9 charles albert tindell,1,9 robert pitti,1 catherine wilson,1 katrina nichols,2 tommy kaiwai cheung,2 hyojin kim,1 matthew wongchenko,4 yibing yan,4 benjamin haley,5 trinna cuellar,5 joshua webster,6. With cancer drug resistance, we aim to establish a forum for papers dealing with all aspects of drug resistance. Addressing drug resistance in cancer with macromolecular. Although, quite often multidrug resistance is associated to the overexpression of the membrane efflux pump pglycoprotein, other mechanisms may account for the observed resistance of dreng2 and ddreng2 cells. During this progression, cancer cells not only change their response.
Treatment resistance that develops as cancer cells evolve is one of the major limitations of targeted cancer therapies today. These mutations inevitably cause recurrence and often progression to a more aggressive form. In fact, when resistance to a drug is induced, an increase in the percentage of cells possessing csc markers has been observed. The geneticnongenetic duality of drug resistance in cancer. So far, this issue has been discussed based on the mechanisms by which cancer cells become resistant, such as drug inactivation, alterations in cellular targets, suppression of drug. These transporters serve as the guardians of the stem cell population in the body. Novel drug may be the answer in battling resistance in. This paper outlines the current knowledge of mechanisms that promote or enable drug resistance, such as drug inactivation, drug target alteration, drug efflux, dna damage repair, cell. Both clinical and experimental aspects of drug resistance in cancer are included. The role of telomerase activation in the expression andor maintenance of drug resistance is not clearly understood. This paper outlines the current knowledge of mechanisms that promote or enable drug resistance, such as drug inactivation, drug target alteration, drug efflux, dna damage repair, cell death inhibition.
Cancer stem cells cscs, also known as tumorinitiating cells tics, are suggested to be responsible for drug resistance and cancer relapse due in part to their ability to selfrenew themselves and differentiate into heterogeneous lineages of cancer cells. While characterizing a drug resistant breast cancer cell line, mcf7advp3000, we found that fatty acid synthase fasn is overexpressed. This process selfadjusts over time, with the cancer cells emitting more pglycoprotein in each exposure to the chemotherapy agent. More than 30 years ago, they discovered that in some cases, when patients go from being sensitive to resistant to treatment, their cancer cells start to overexpress abc. Nsclc show resistance to these drugs that has led to an increase in mortality rates. The authors suggest that the implementation of in vitro drug susceptibility testing before chemotherapy can effectively prevent the occurrence of primary drug resistance and inappropriate drug treatment for individuals with lung cancer. Chemosensitivity and chemoresistance assays in cancer. This is a very serious problem that may lead to recurrence of disease or even death. Control of multidrug resistance gene mdr1 and cancer. One of the main causes behind the failure of treatment is the development of various therapy resistance mechanisms by the cancer cells leading to the recurrence of the disease. Patients may respond well at first, but relapse is inevitable for many cancer patients, despite many improvements in drugs and their use over the last 40 years. Lung cancer, resistance to gemcitabine and cisplatin, transition phenotypes. Various treatments are coming up recently, and combination therapy of chemotherapeutic agent and chemosensitizer molecule is one of the effective approaches to combat the multidrug resistance of antineoplastic drugs in cancer cells. It is likely that the principle of collateral sensitivity can be exploited to.
445 1193 146 221 875 1559 1208 97 192 1026 152 1348 1488 424 1392 772 1216 380 515 1592 1171 949 467 96 297 1481 889 1034 290 1311 812 233 1265 873 325 1278 593 616